HAL (France)open access
Analysis of interstitial lung disease in pharmacovigilance databases: Coding challenges and interpretation biases - An update
Interstitial lung disease, Risk assessment, 1, Pharmacovigilance, 2, 0, Disproportionality analysis, Adverse effect
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 178083
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.